| Application no. and date | 13812075.3 (espacenet) (Federated) (European Patent Register), 20130829 | | Patent/reg. no. and date | DK/EP 2890687, 20170628 | | Publication date | 20150708 | | Priority no. and date | IQ 2392012, 20120830 | | EP pub. no. and date |
EP 2890687 20150708 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | SH/GP/155561 | | Inventor | TUFILLI, Nicola, Novartis Pharma AG
Postfach
4002 Basel, CH,
GRANDEURY, Arnaud, Novartis Pharma AG
Postfach
4002 Basel, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/428 (2006.01) , A61P 21/00 (2006.01) , C07D 277/68 (2006.01) | | Title | Salte af benzothiazolonforbindelse som beta-2-adrenoceptoragonist | | Int. application no. | IB2013058109 | | Int. publication no. | WO2014033654 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
